PRQR

PROQR THRAPEUTICS N V

PRQR·N71542109·US·Common Stock·Healthcare - Biotechnology-Activist

PRQR (PROQR THRAPEUTICS N V) is held by 32 institutional investors as of Q2 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($16.8M), Aberdeen Group plc ($16.6M), Woodline Partners LP ($6.1M). Net institutional sentiment: Mixed.

32
Holders
(1 Elite)
$53.2M
Total Value
57% (30)
Consensus
17 buying - 13 selling
13F: Insider & Congress: Updated regularly
PRQR

Smart Money Verdict

View all
Loading verdict
Held by 32 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jul 21, 2026 · Activists Jul 29, 2026 · Congress none

ActivistVHVan Herk Investments B.V.10.9%Jul 29, 2026
ActivistAberdeen Group plcAberdeen Group plc6.3%Jul 29, 2026
ActivistELELI LILLY & Co15.6%Jul 24, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9M(+44.2%)$16.8M0.0%-54.68%
38
Increased
8.9M(+169.3%)$16.6M0.0%+32.27%
46
New
3.3M$6.1M0.0%+26.34%
38
Increased
1.8M(+36.0%)$3.3M0.0%+25.72%
34
Increased
1.2M(+68.4%)$2.2M0.0%+22.72%
38
Increased
1.1M(+23.9%)$2.1M0.0%+14.46%
32
Increased
639,243(+109.4%)$1.2M0.0%+19.68%
41
Unchanged
620,000$1.2M0.0%+17.50%
0
Increased
571,073(+4.6%)$1.1M0.0%+22.32%
26
Increased
455,104(+1267.1%)$846,4930.0%+25.80%
40
Increased
275,631(+59.9%)$512,6740.0%+22.50%
35
Decreased
161,004(-17.1%)$299,4670.0%+0.11%
0
Unchanged
108,762$202,2970.0%+18.69%
0
Unchanged
85,000$158,1000.0%+22.73%
0
Increased
84,806(+604.7%)$157,7390.0%+24.39%
36
Decreased
58,040(-68.7%)$107,9540.0%+5.86%
0
Decreased
57,997(-31.7%)$107,8740.0%-51.64%
0
Decreased
50,652(-93.3%)$94,2130.0%-9.59%
0
Increased
39,954(+44.5%)$74,3140.0%+28.66%
29
Increased
35,241(+2610.8%)$65,5480.0%+25.14%
34

Showing 1-20 of 40

1 / 2
PRQRPRQRPROQR THRAPEUTICS N V

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used